GUANINE-NUCLEOTIDE REGULATION OF AGONIST INTERACTIONS AT [H-3] SCH23390-LABELED D1 DOPAMINE-RECEPTORS IN RAT STRIATUM

被引：131
作者：
HESS, EJ
BATTAGLIA, G
NORMAN, AB
IORIO, LC
CREESE, I
机构：
[1] UNIV CALIF SAN DIEGO,SCH MED,DEPT NEUROSCI,LA JOLLA,CA 92093
[2] SCHERING PLOUGH CORP,BLOOMFIELD,NJ 07003
来源：
EUROPEAN JOURNAL OF PHARMACOLOGY | 1986年 / 121卷 / 01期
关键词：
D O I：
10.1016/0014-2999(86)90389-4
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：31 / 38
页数：8
相关论文
共 28 条
[1]   GUANYL NUCLEOTIDE AND DIVALENT-CATION REGULATION OF CORTICAL-S2 SEROTONIN RECEPTORS [J].
BATTAGLIA, G ;
SHANNON, M ;
TITELER, M .
JOURNAL OF NEUROCHEMISTRY, 1984, 43 (05) :1213-1219
[2]   D2-DOPAMINE RECEPTOR-MEDIATED INHIBITION OF FORSKOLIN-STIMULATED ADENYLATE-CYCLASE ACTIVITY IN RAT STRIATUM [J].
BATTAGLIA, G ;
NORMAN, AB ;
HESS, EJ ;
CREESE, I .
NEUROSCIENCE LETTERS, 1985, 59 (02) :177-182
[3]   CHARACTERIZATION OF THE BINDING OF H-3-SCH 23390, A SELECTIVE D-1 RECEPTOR ANTAGONIST LIGAND, IN RAT STRIATUM [J].
BILLARD, W ;
RUPERTO, V ;
CROSBY, G ;
IORIO, LC ;
BARNETT, A .
LIFE SCIENCES, 1984, 35 (18) :1885-1893
[4]  
BOEYNAEMS JM, 1975, J CYCLIC NUCL PROT, V1, P123
[5]   PHARMACOLOGICAL EFFECTS OF A SPECIFIC DOPAMINE D-1 ANTAGONIST SCH-23390 IN COMPARISON WITH NEUROLEPTICS [J].
CHRISTENSEN, AV ;
ARNT, J ;
HYTTEL, J ;
LARSEN, JJ ;
SVENDSEN, O .
LIFE SCIENCES, 1984, 34 (16) :1529-1540
[6]   PREFERENTIAL INHIBITION OF LIGAND-BINDING TO CALF STRIATAL DOPAMINE D1-RECEPTORS BY SCH-23390 [J].
CROSS, AJ ;
MASHAL, RD ;
JOHNSON, JA ;
OWEN, F .
NEUROPHARMACOLOGY, 1983, 22 (11) :1327-1329
[7]  
GIL DW, 1985, J PHARMACOL EXP THER, V232, P608
[8]   H-3-DOPAMINE BINDING TO RAT STRIATAL D-2 AND D-3 SITES - ENHANCEMENT BY MAGNESIUM AND INHIBITION BY GUANINE-NUCLEOTIDES AND SODIUM [J].
HAMBLIN, MW ;
CREESE, I .
LIFE SCIENCES, 1982, 30 (18) :1587-1595
[9]   INTERACTIONS OF AGONISTS WITH D-2 DOPAMINE-RECEPTORS - EVIDENCE FOR A SINGLE RECEPTOR POPULATION EXISTING IN MULTIPLE AGONIST AFFINITY-STATES IN RAT STRIATAL MEMBRANES [J].
HAMBLIN, MW ;
LEFF, SE ;
CREESE, I .
BIOCHEMICAL PHARMACOLOGY, 1984, 33 (06) :877-887
[10]  
HEIDENRICH KA, 1980, J CYCL NUCL, V6, P271
123